Holdings of Select Biotechnology Portfolio
Fidelity Select Portfolios ·161 declared positions · as of Feb 28, 2026
Original filing · Net assets 5.4B $ · Ten largest lines: 55.1 % of the equity sleeve
Sector breakdown
- Health care 47.5 %
- Industrials 0.7 %
- Unattributed 51.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 95.9 %
- EUR 2.4 %
- CHF 0.9 %
- DKK 0.8 %
- SEK 0.1 %
The quoted currency of each line, as declared.
Country breakdown
- US 87.5 %
- DK 3.3 %
- NL 2.8 %
- BE 2.2 %
- BM 1.1 %
- CH 0.9 %
- FR 0.8 %
- VG 0.4 %
- CA 0.3 %
- IE 0.2 %
- DE 0.2 %
- SG 0.1 %
- Other countries 0.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 135 | 4.6B $ | 87.48 % |
| 2 | DK | 3 | 173.2M $ | 3.29 % |
| 3 | NL | 4 | 148.8M $ | 2.83 % |
| 4 | BE | 1 | 116.3M $ | 2.21 % |
| 5 | BM | 1 | 57.1M $ | 1.09 % |
| 6 | CH | 2 | 45.9M $ | 0.87 % |
| 7 | FR | 2 | 44.4M $ | 0.84 % |
| 8 | VG | 1 | 18.5M $ | 0.35 % |
| 9 | CA | 2 | 15.2M $ | 0.29 % |
| 10 | IE | 3 | 11.8M $ | 0.22 % |
| 11 | DE | 1 | 9.4M $ | 0.18 % |
| 12 | SG | 1 | 6.8M $ | 0.13 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | AbbVie Inc | 3,049,432 | 707.7M $ | 13.22 % |
| 2 | Krystal Biotech Inc | 1,806,522 | 497.9M $ | 9.30 % |
| 3 | Gilead Sciences Inc | 3,149,952 | 469.2M $ | 8.77 % |
| 4 | Amgen Inc | 1,149,551 | 446.2M $ | 8.34 % |
| 5 | Alnylam Pharmaceuticals Inc | 496,683 | 165.4M $ | 3.09 % |
| 6 | Praxis Precision Medicines Inc | 390,500 | 131.5M $ | 2.46 % |
| 7 | Ascendis Pharma A/S | 558,201 | 130.3M $ | 2.44 % |
| 8 | Insmed Inc | 811,101 | 121.1M $ | 2.26 % |
| 9 | UCB SA | 390,274 | 116.3M $ | 2.17 % |
| 10 | Argenx SE | 149,344 | 114.5M $ | 2.14 % |
| 11 | Regeneron Pharmaceuticals, Inc. | 101,316 | 79.2M $ | 1.48 % |
| 12 | Moderna Inc | 1,432,529 | 76.7M $ | 1.43 % |
| 13 | Scholar Rock Holding Corp | 1,650,449 | 73.1M $ | 1.37 % |
| 14 | Natera Inc | 331,532 | 69M $ | 1.29 % |
| 15 | Cogent Biosciences Inc | 1,691,394 | 65.7M $ | 1.23 % |
| 16 | CENTESSA PHARMACEUTICALS PLC | 2,187,494 | 58.8M $ | 1.10 % |
| 17 | Biogen Inc | 299,435 | 57.4M $ | 1.07 % |
| 18 | Roivant Sciences Ltd | 1,972,719 | 57.1M $ | 1.07 % |
| 19 | Vertex Pharmaceuticals Inc | 112,900 | 56.1M $ | 1.05 % |
| 20 | Bridgebio Pharma Inc | 707,304 | 47M $ | 0.88 % |
| 21 | Protagonist Therapeutics Inc | 506,713 | 46.7M $ | 0.87 % |
| 22 | Immunome Inc | 2,131,664 | 46.6M $ | 0.87 % |
| 23 | Terns Pharmaceuticals Inc | 1,079,186 | 45.5M $ | 0.85 % |
| 24 | Revolution Medicines Inc | 438,772 | 44.8M $ | 0.84 % |
| 25 | Kymera Therapeutics Inc | 462,441 | 42.2M $ | 0.79 % |
| 26 | Ionis Pharmaceuticals Inc | 476,377 | 38.7M $ | 0.72 % |
| 27 | ArriVent Biopharma Inc | 1,680,003 | 38.6M $ | 0.72 % |
| 28 | Crinetics Pharmaceuticals Inc | 926,671 | 38.1M $ | 0.71 % |
| 29 | Abivax SA | 301,600 | 36.6M $ | 0.68 % |
| 30 | Structure Therapeutics Inc | 564,438 | 35.5M $ | 0.66 % |
| 31 | Disc Medicine Inc | 532,174 | 35.5M $ | 0.66 % |
| 32 | Galderma Group AG | 184,660 | 34.8M $ | 0.65 % |
| 33 | Zealand Pharma A/S | 589,130 | 33.9M $ | 0.63 % |
| 34 | Cytokinetics Inc | 503,175 | 31.3M $ | 0.59 % |
| 35 | Candel Therapeutics Inc | 5,911,951 | 31M $ | 0.58 % |
| 36 | Viridian Therapeutics Inc | 1,001,204 | 29.4M $ | 0.55 % |
| 37 | Vaxcyte Inc | 470,455 | 29M $ | 0.54 % |
| 38 | Stoke Therapeutics Inc | 792,594 | 28.9M $ | 0.54 % |
| 39 | Nuvalent Inc | 273,399 | 27.9M $ | 0.52 % |
| 40 | Apogee Therapeutics Inc | 392,757 | 27.5M $ | 0.51 % |
| 41 | Trevi Therapeutics Inc | 2,288,485 | 27.3M $ | 0.51 % |
| 42 | Annexon Inc | 4,733,596 | 26.5M $ | 0.50 % |
| 43 | Arrowhead Pharmaceuticals Inc | 409,378 | 25.9M $ | 0.48 % |
| 44 | Dianthus Therapeutics Inc | 432,218 | 23.9M $ | 0.45 % |
| 45 | Vor BioPharma Inc | 1,536,125 | 23.7M $ | 0.44 % |
| 46 | Edgewise Therapeutics Inc | 776,925 | 23.6M $ | 0.44 % |
| 47 | United Therapeutics Corp | 44,593 | 22.5M $ | 0.42 % |
| 48 | Intellia Therapeutics Inc | 1,607,833 | 22.2M $ | 0.41 % |
| 49 | Travere Therapeutics Inc | 720,343 | 21.5M $ | 0.40 % |
| 50 | Dyne Therapeutics Inc | 1,368,144 | 21.4M $ | 0.40 % |
| 51 | Corcept Therapeutics Inc | 575,646 | 20.6M $ | 0.38 % |
| 52 | Ideaya Biosciences Inc | 637,957 | 20.5M $ | 0.38 % |
| 53 | Madrigal Pharmaceuticals Inc | 47,495 | 20.5M $ | 0.38 % |
| 54 | Newamsterdam Pharma Co NV | 562,500 | 19.9M $ | 0.37 % |
| 55 | Amylyx Pharmaceuticals Inc | 1,219,575 | 18.5M $ | 0.35 % |
| 56 | Biohaven Ltd | 1,603,096 | 18.5M $ | 0.35 % |
| 57 | Summit Therapeutics Inc | 1,089,169 | 18.1M $ | 0.34 % |
| 58 | Spyre Therapeutics Inc | 401,953 | 17.3M $ | 0.32 % |
| 59 | Arcus Biosciences Inc | 831,100 | 16.9M $ | 0.32 % |
| 60 | Olema Pharmaceuticals Inc | 693,100 | 16.8M $ | 0.31 % |
| 61 | Alumis Inc | 561,900 | 16.7M $ | 0.31 % |
| 62 | Oruka Therapeutics Inc | 475,783 | 16.4M $ | 0.31 % |
| 63 | Bicara Therapeutics Inc | 944,900 | 15.9M $ | 0.30 % |
| 64 | Axsome Therapeutics Inc | 92,303 | 15.1M $ | 0.28 % |
| 65 | Replimune Group Inc | 1,864,545 | 14.3M $ | 0.27 % |
| 66 | Maze Therapeutics Inc | 311,885 | 14.2M $ | 0.27 % |
| 67 | Rapport Therapeutics Inc | 471,773 | 13.7M $ | 0.26 % |
| 68 | Viking Therapeutics Inc | 404,257 | 13.7M $ | 0.26 % |
| 69 | DAMORA THERAPEUTICS INC | 454,559 | 13.4M $ | 0.25 % |
| 70 | BEONE MEDICINES LTD | 41,698 | 13.2M $ | 0.25 % |
| 71 | Xenon Pharmaceuticals Inc | 297,364 | 12.9M $ | 0.24 % |
| 72 | Nuvation Bio Inc | 2,164,933 | 12.8M $ | 0.24 % |
| 73 | Mineralys Therapeutics Inc | 421,700 | 12.3M $ | 0.23 % |
| 74 | Kiniksa Pharmaceuticals International Plc | 267,500 | 11.9M $ | 0.22 % |
| 75 | Solid Biosciences Inc | 1,791,160 | 11.1M $ | 0.21 % |
| 76 | Idorsia Ltd | 2,174,283 | 11.1M $ | 0.21 % |
| 77 | Geron Corp | 6,492,512 | 10.9M $ | 0.20 % |
| 78 | Enliven Therapeutics Inc | 363,267 | 10.8M $ | 0.20 % |
| 79 | Tectonic Therapeutic Inc | 442,889 | 10.4M $ | 0.19 % |
| 80 | Immunocore Holdings PLC | 321,500 | 10.4M $ | 0.19 % |
| 81 | uniQure NV | 650,282 | 10.2M $ | 0.19 % |
| 82 | ZENAS BIOPHARMA INC | 380,400 | 10M $ | 0.19 % |
| 83 | VTV THERAPEUTICS INC | 260,391 | 9.9M $ | 0.19 % |
| 84 | BioNTech SE | 85,400 | 9.4M $ | 0.18 % |
| 85 | Forte Biosciences Inc | 310,965 | 9.4M $ | 0.18 % |
| 86 | Rhythm Pharmaceuticals Inc | 99,803 | 9.3M $ | 0.17 % |
| 87 | PTC Therapeutics Inc | 134,511 | 9.2M $ | 0.17 % |
| 88 | Gubra A/S | 145,554 | 9M $ | 0.17 % |
| 89 | Capricor Therapeutics Inc | 314,700 | 8.8M $ | 0.16 % |
| 90 | Twist Bioscience Corp | 170,825 | 8M $ | 0.15 % |
| 91 | SENSORION SA | 18,153,474 | 7.8M $ | 0.15 % |
| 92 | Aktis Oncology Inc | 383,955 | 7.7M $ | 0.14 % |
| 93 | MannKind Corp | 2,185,101 | 7.2M $ | 0.13 % |
| 94 | Ocular Therapeutix Inc | 784,000 | 7M $ | 0.13 % |
| 95 | Beam Therapeutics Inc | 244,914 | 7M $ | 0.13 % |
| 96 | Immunovant Inc | 250,021 | 6.9M $ | 0.13 % |
| 97 | WaVe Life Sciences Ltd | 487,140 | 6.8M $ | 0.13 % |
| 98 | CytomX Therapeutics Inc | 1,222,540 | 6.6M $ | 0.12 % |
| 99 | Tango Therapeutics Inc | 586,000 | 6.5M $ | 0.12 % |
| 100 | Immuneering Corp | 1,290,698 | 6.4M $ | 0.12 % |